Kevin F. McLaughlin, SVP, CFO and Treasurer at ACCELERON PHARMA INC (XLRN), sold 50,000 shares at $161.26 ($8.0M) on 2021-09-23, disclosed to the SEC on 2021-09-24.
Open-market sale of $8.0M XLRN by SVP, CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $160.26 | 18,647 | $3.0M | 37.3% |
| 2 | $160.26 | 18,647 | $3.0M | 37.3% |
| 3 | $161.26 | 983 | $159K | 2.0% |
| 4 | $161.26 | 983 | $159K | 2.0% |
| 5 | $160.38 | 5,370 | $861K | 10.7% |
| 6 | $160.38 | 5,370 |
| $861K |
| 10.7% |
| Total | $160.33 avg | 50,000 | $8.0M | 100% |
| Filing → |
| VCEL | SELL | 2026-02-13 | $243K | — | Filing → |
| IVVD | BUY | 2025-11-20 | $125K | — | Filing → |
| VCEL | SELL | 2025-11-12 | $270K | — | Filing → |